SBI Holdings, Inc.
8473.T · Tokyo Stock Exchange · JPY
2.884,50JPY
+31,50 (+1,10 %)Stand 11. Nov., 3:55
Kennzahlen
- Eröffnung
- 2.853,00
- Vortag
- 2.853,00
- Tagesspanne
- 2.850,00 – 2.893,50
- 52 Wochen
- 2.631,00 – 3.866,00
- Volumen
- 1,6 Mio.
- Ø Volumen
- 4,14 Mio.
- Börsenwert
- 1,86 Bio. ¥
- KGV
- 3,8
- Gewinn je Aktie (TTM)
- 729,55
- Dividendenrendite
- 3,6 %
- Beta
- 0,5
- Nächste Zahlen
- 10. Feb. 2027
Finanzen
| JPY | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Umsatz | 1,9 Bio. | 1,35 Bio. | 1,19 Bio. | 911,97 Mrd. | 650,48 Mrd. |
| Herstellungskosten | 771,84 Mrd. | 384,87 Mrd. | 359,59 Mrd. | 279,06 Mrd. | 276,52 Mrd. |
| Bruttogewinn | 1,12 Bio. | 968,76 Mrd. | 829,91 Mrd. | 632,92 Mrd. | 373,96 Mrd. |
| Forschung und Entwicklung | 0 | 0 | 0 | 0 | 0 |
| Vertrieb und Verwaltung | 0 | 0 | 0 | 0 | 0 |
| Operatives Ergebnis | 516,59 Mrd. | 607,05 Mrd. | 413,98 Mrd. | 295,35 Mrd. | 204,72 Mrd. |
| EBITDA | 584,32 Mrd. | 581,39 Mrd. | 404,96 Mrd. | 278,63 Mrd. | 487 Mrd. |
| Nettogewinn | 427,58 Mrd. | 162,12 Mrd. | 87,24 Mrd. | 35,45 Mrd. | 366,85 Mrd. |
| Gewinn je Aktie (verwässert) | 624,54 | 256,34 | 142,80 | 59,17 | 642,95 |
Bewertung
Letzte 12 Monate
- KGV
- 3,8
- Kurs-Umsatz-Verhältnis
- 0,9
- Kurs-Buchwert-Verhältnis
- 1,0
- PEG
- 0,1
- Bruttomarge
- 70,8 %
- Operative Marge
- 39,1 %
- Nettomarge
- 24,1 %
- Verschuldungsgrad
- 4,0
- EV/EBITDA
- 3,9
- Eigenkapitalrendite
- 26,8 %
- Kapitalrendite (ROIC)
- 1,6 %
- Free-Cashflow-Rendite
- 41,1 %
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | |
|---|---|---|---|---|---|
| Bruttomarge | 59,3 % | 71,6 % | 69,8 % | 69,4 % | 57,5 % |
| Operative Marge | 27,2 % | 44,8 % | 34,8 % | 32,4 % | 31,5 % |
| Nettomarge | 22,5 % | 12,0 % | 7,3 % | 3,9 % | 56,4 % |
| KGV | 4,3 | 7,4 | 12,0 | 19,6 | 2,1 |
| Kurs-Umsatz-Verhältnis | 1,0 | 0,9 | 0,9 | 0,8 | 1,2 |
| Kurs-Buchwert-Verhältnis | 1,0 | 1,0 | 0,8 | 0,7 | 0,8 |
| Verschuldungsgrad | 3,9 | 6,1 | 4,8 | 5,1 | 3,7 |
| Liquidität 3. Grades | 9,9 | 1,2 | 0,8 | 1,2 | 1,4 |
| Dividendenrendite | 3,0 % | 4,0 % | 3,9 % | 5,4 % | 4,2 % |
| Unternehmenswert | 2,44 Bio. | 3,44 Bio. | 2,47 Bio. | 2,66 Bio. | 1,68 Bio. |
| EV/EBITDA | 4,2 | 5,9 | 6,1 | 9,6 | 3,4 |
| Eigenkapitalrendite | 23,8 % | 12,9 % | 6,9 % | 3,5 % | 39,7 % |
| Kapitalrendite (ROIC) | 1,1 % | 4,0 % | 4,0 % | 2,0 % | 1,9 % |
| Free-Cashflow-Rendite | 0,0 % | 138,4 % | 135,8 % | 145,5 % | −19,7 % |
Wachstum
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | |
|---|---|---|---|---|---|
| Umsatz | +40,1 % | +13,8 % | +30,4 % | +40,2 % | +24,6 % |
| Bruttogewinn | +16,1 % | +16,7 % | +31,1 % | +69,2 % | +11,0 % |
| Operatives Ergebnis | −14,9 % | +46,6 % | +40,2 % | +44,3 % | +18,8 % |
| Nettogewinn | +163,7 % | +85,8 % | +146,1 % | −90,3 % | +352,4 % |
| Gewinn je Aktie | +143,6 % | +79,5 % | +141,3 % | −90,8 % | +333,1 % |
| Freier Cashflow | −100,0 % | +17,2 % | +40,7 % | +776,7 % | −218,2 % |
| Dividende je Aktie | +8,6 % | +7,6 % | +4,6 % | +9,3 % | +33,0 % |
Analysten
Einstufungen
Gerade nicht verfügbar.
Kursziel
Gerade nicht verfügbar.
Schätzungen
| FY 2027 | FY 2028 | FY 2029 | |
|---|---|---|---|
| Umsatz (Ø) | 1,65 Bio. | 1,64 Bio. | 1,71 Bio. |
| Umsatz (Tief – Hoch) | 1,57 Bio. – 1,73 Bio. | 1,51 Bio. – 1,77 Bio. | 1,53 Bio. – 1,92 Bio. |
| Gewinn je Aktie (Ø) | 466,39 | 340,38 | 356,28 |
| Gewinn je Aktie (Tief – Hoch) | 440,79 – 482,29 | 238,06 – 439,58 | 237,96 – 468,40 |
| Analysten | 2 | 6 | 5 |
Quartalszahlen
Nächste Zahlen: 10. Feb. 2027| Nov. 2026 | Juli 2026 | Mai 2026 | Feb. 2026 | Okt. 2025 | Juli 2025 | Mai 2025 | Feb. 2025 | |
|---|---|---|---|---|---|---|---|---|
| Gewinn je Aktie · Erwartet | 90,11 | 104,45 | 101,36 | 170,15 | 49,22 | 71,64 | 51,85 | 117,63 |
| Gewinn je Aktie · Tatsächlich | 127,63 | 229,07 | 120,28 | 282,77 | 129,43 | 139,60 | 195,37 | 93,29 |
| Abweichung | +41,64 % | +119,31 % | +18,67 % | +66,19 % | +162,96 % | +94,86 % | +276,80 % | −20,69 % |
| Umsatz · Tatsächlich | 487,57 Mrd. | 571,01 Mrd. | 406,95 Mrd. | 587,1 Mrd. | 478,83 Mrd. | 443,19 Mrd. | 430,34 Mrd. | 337,36 Mrd. |
Dividenden und Splits
| Ex-Tag | Zahltag | Betrag |
|---|---|---|
| 30. März 2027 | 30. März 2027 | 80,00 |
| 29. Sept. 2026 | 14. Dez. 2026 | 30,00 |
| 30. März 2026 | 8. Juni 2026 | 75,00 |
| 29. Sept. 2025 | 15. Dez. 2025 | 40,00 |
| 28. März 2025 | 9. Juni 2025 | 140,00 |
| 27. Sept. 2024 | 16. Dez. 2024 | 30,00 |
| 28. März 2024 | 7. Juni 2024 | 130,00 |
| 28. Sept. 2023 | 18. Dez. 2023 | 30,00 |
| 30. März 2023 | 9. Juni 2023 | 120,00 |
| 29. Sept. 2022 | 19. Dez. 2022 | 30,00 |
| 30. März 2022 | 30. Juni 2022 | 120,00 |
| 29. Sept. 2021 | 13. Dez. 2021 | 30,00 |
Aktiensplits
- 27. Nov. 20252:1
- 26. Sept. 201210:1
- 6. Aug. 20043:1
- 25. Nov. 20033:1
- 25. Sept. 20013:1
Eigentümer
Institutionen
Gerade nicht verfügbar.
Insider-Geschäfte
–
Vergleichbare Unternehmen
2885.TWYuanta Financial Holding Co., Ltd.69,80+1,01 %
4280.SRKingdom Holding Company13,10+2,26 %
4755.TRakuten Group, Inc.645,90−0,63 %
4819.TDigital Garage, Inc.2.126,00−4,45 %
8789.TFinTech Global Incorporated112,00+1,82 %
BAJAJFINSV.NSBajaj Finserv Ltd.1.861,90+1,36 %
EXO.ASExor N.V.74,30−0,07 %
HAL.ASHAL Trust171,00+0,12 %
Über das Unternehmen
SBI Holdings, Inc. is a Japanese conglomerate primarily engaged in online financial services and strategic investments, both domestically and internationally. Its operations are structured around three key pillars: Financial Services, Asset Management, and the Biotechnology, Healthcare, and Medical Informatics sectors. The company provides a comprehensive suite of financial products, including online brokerage, investment banking, and internet banking facilities. It offers various insurance solutions such as automobile, health (cancer), property (fire, earthquake), and life coverage, alongside short-term insurance. Further financial offerings encompass foreign exchange (FX) margin trading, online securities, and services related to digital asset exchange and transactions. SBI also manages defined-contribution pension schemes, provides leasing and lending services, and operates a proprietary trading system. Its involvement extends to e-commerce settlement processing, remittance services, and essential back-office support. Beyond traditional banking, SBI is active in private equity and venture capital fund management, offers mergers and acquisitions (M&A) advisory, and runs savings and commercial banking operations. It provides investment advisory and management services, alongside rating information services. The firm also deals with real estate-secured loans and offers rent guarantees for residential properties. In the biotechnology and healthcare domain, SBI conducts research, manufactures, and distributes pharmaceutical products, health supplements, and cosmetics. It develops, produces, sells, and maintains integrated medical information systems. Furthermore, it's involved in the research and development of advanced antibody and nucleic acid drugs targeting cancer and immunological conditions. The company's diverse portfolio includes operating a fund-raising platform, serving as a crypto-asset broker, and developing, manufacturing, and selling crypto-asset mining systems. It also develops and manages cybersecurity systems, provides blockchain platforms, invests in real estate, and engages in used car exports. Additionally, SBI offers healthcare services, participates in revitalization projects, mines digital assets, and is involved in e-sports and renewable energy initiatives. Established in 1999, the company was initially known as Softbank Investment Corporation before adopting its current name, SBI Holdings, Inc., in July 2005. Its headquarters are located in Tokyo, Japan.
Führung
- Yoshitaka KitaoChairman, President, CEO & Representative Director
- Masato TakamuraSenior EVice President, Chief Operating Officer, Senior Head of Financial Services Business & Representative Director
- Tomoya AsakuraSenior Executive Vice President & Representative Director
- Hideyuki KatsuchiExecutive Officer of Accounting & Finance
- Masashi OkuyamaExecutive Officer, GM of the Legal & Compliance and Director
- Motoaki ShiinoGM of Corporate Communication Department & Director
- CEO
- Yoshitaka Kitao
- Mitarbeitende
- 18.669
- Hauptsitz
- Tokyo, TY, JP
- Sektor
- Financial Services
- Branche
- Financial - Conglomerates
- Börsengang
- 4. Jan. 2001
- Website
- sbigroup.co.jp
Nachrichten
Gerade keine Nachrichten zu diesem Unternehmen.
Kurse mindestens 15 Minuten verzögert. Daten: Financial Modeling Prep. Keine Anlageberatung.